Company intelligence / Profile preview

Zhongchuang Yike

Shanghai, Shanghai, China

Ownership: Private
Employees: ~100
Development stage: Other

Overview

The company has developed and commercialized over 102 functional strains, with clinical studies supporting effects for metabolic health and hyperuricemia intervention in preclinical mouse models. Products are commercialized across food, supplement, and pharmaceutical channels.

Therapeutic areas: Metabolic DisordersRheumatologyGastroenterology
Modalities: ProbioticsPostbioticsFermentation agent
Industry: Biotech

Partnerships

National Dairy Technology Innovation CenterChronic Risk Exposure and Chronic Disease Research InstituteSchool of Public Health at Zhejiang Chinese Medical UniversityShenyang Normal University

Beyond the preview

Go deeper on Zhongchuang Yike.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhongchuang Yike.

Explore the full profile